CHARLIE DAVIS: Open Payments
NPI 1710462924 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 72 payments from 17 companies in 2025. Trend: 2023 $696 · 2024 $1,002 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $277 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $197 |
| E.R. Squibb & Sons, L.L.C. | 21 | $167 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Amgen Inc. | 4 | $61 |
| Boston Scientific Corporation | 3 | $58 |
| PFIZER INC. | 2 | $36 |
| Smith+Nephew, Inc. | 2 | $35 |
| Stryker Corporation | 2 | $32 |
| Averitas Pharma Inc. | 1 | $24 |
Products named: LEQVIO, LifeVest, ELIQUIS, TRELEGY ELLIPTA, REPATHA, AVVIGO Guidance System, VYNDAQEL, CLOTTRIEVER BOLD CATHETER.
Industry payments across KY — which companies pay providers there.
